Bioorganometallic chemistry—from teaching paradigms to medicinal applications CG Hartinger, PJ Dyson Chemical Society Reviews 38 (2), 391-401, 2009 | 1078 | 2009 |
KP1019, a new redox‐active anticancer agent–Preclinical development and results of a clinical phase I study in tumor patients CG Hartinger, MA Jakupec, S Zorbas‐Seifried, M Groessl, A Egger, ... Chemistry & biodiversity 5 (10), 2140-2155, 2008 | 1026 | 2008 |
Homogeneous catalysis for sustainable hydrogen storage in formic acid and alcohols K Sordakis, C Tang, LK Vogt, H Junge, PJ Dyson, M Beller, G Laurenczy Chemical reviews 118 (2), 372-433, 2018 | 993 | 2018 |
In vitro and in vivo evaluation of ruthenium (II)− arene PTA complexes C Scolaro, A Bergamo, L Brescacin, R Delfino, M Cocchietto, G Laurenczy, ... Journal of medicinal chemistry 48 (12), 4161-4171, 2005 | 985 | 2005 |
Efficient dehydrogenation of formic acid using an iron catalyst A Boddien, D Mellmann, F Gärtner, R Jackstell, H Junge, PJ Dyson, ... Science 333 (6050), 1733-1736, 2011 | 848 | 2011 |
Ruthenium in medicine: current clinical uses and future prospects CS Allardyce, PJ Dyson Platinum Metals Review 45 (2), 62-69, 2001 | 751 | 2001 |
A viable hydrogen-storage system based on selective formic acid decomposition with a ruthenium catalyst C Fellay, PJ Dyson, G Laurenczy Angewandte Chemie, International Edition 47 (21), 3966-8, 2008 | 741 | 2008 |
Why are ionic liquids liquid? A simple explanation based on lattice and solvation energies I Krossing, JM Slattery, C Daguenet, PJ Dyson, A Oleinikova, ... Journal of the American Chemical Society 128 (41), 13427-13434, 2006 | 741 | 2006 |
Direct synthesis of formic acid from carbon dioxide by hydrogenation in acidic media S Moret, PJ Dyson, G Laurenczy Nature communications 5 (1), 4017, 2014 | 696 | 2014 |
Selective degradation of wood lignin over noble‐metal catalysts in a two‐step process N Yan, C Zhao, PJ Dyson, C Wang, L Liu, Y Kou ChemSusChem: Chemistry & Sustainability Energy & Materials 1 (7), 626-629, 2008 | 638 | 2008 |
Targeted delivery and controlled release of doxorubicin to cancer cells using modified single wall carbon nanotubes X Zhang, L Meng, Q Lu, Z Fei, PJ Dyson Biomaterials 30 (30), 6041-6047, 2009 | 613 | 2009 |
Challenges and opportunities in the development of organometallic anticancer drugs CG Hartinger, N Metzler-Nolte, PJ Dyson Organometallics 31 (16), 5677-5685, 2012 | 606 | 2012 |
Metal-based antitumour drugs in the post genomic era PJ Dyson, G Sava Dalton Transactions, 1929-1933, 2006 | 603 | 2006 |
Classical and non‐classical ruthenium‐based anticancer drugs: Towards targeted chemotherapy W Han Ang, PJ Dyson European Journal of Inorganic Chemistry 2006 (20), 4003-4018, 2006 | 601 | 2006 |
A well‐defined iron catalyst for the reduction of bicarbonates and carbon dioxide to formates, alkyl formates, and formamides C Federsel, A Boddien, R Jackstell, R Jennerjahn, PJ Dyson, R Scopelliti, ... Angewandte Chemie International Edition 50 (49), 9777-9780, 2010 | 536 | 2010 |
From dysfunction to bis‐function: on the design and applications of functionalised ionic liquids Z Fei, TJ Geldbach, D Zhao, PJ Dyson Chemistry–A European Journal 12 (8), 2122-2130, 2006 | 519 | 2006 |
Ultrathin rhodium nanosheets H Duan, N Yan, R Yu, CR Chang, G Zhou, HS Hu, H Rong, Z Niu, J Mao, ... Nature communications 5 (1), 3093, 2014 | 499 | 2014 |
Nitrile-functionalized pyridinium ionic liquids: Synthesis, characterization, and their application in carbon− carbon coupling reactions D Zhao, Z Fei, TJ Geldbach, R Scopelliti, PJ Dyson Journal of the American Chemical Society 126 (48), 15876-15882, 2004 | 494 | 2004 |
The development of RAPTA compounds for the treatment of tumors BS Murray, MV Babak, CG Hartinger, PJ Dyson Coordination Chemistry Reviews 306, 86-114, 2016 | 485 | 2016 |
The “Complex‐in‐a‐Complex” Cations [(acac)2M⊂Ru6(p‐iPrC6H4Me)6(tpt)2(dhbq)3]6+: A Trojan Horse for Cancer Cells B Therrien, G Süss‐Fink, P Govindaswamy, AK Renfrew, PJ Dyson Angewandte Chemie 120 (20), 3833-3836, 2008 | 479 | 2008 |